Cargando…

A novel expression platform for the production of diabetes-associated autoantigen human glutamic acid decarboxylase (hGAD65)

BACKGROUND: Human glutamic acid decarboxylase 65 (hGAD65) is a key autoantigen in type 1 diabetes, having much potential as an important marker for the prediction and diagnosis of type 1 diabetes, and for the development of novel antigen-specific therapies for the treatment of type 1 diabetes. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaofeng, Brandsma, Martin, Tremblay, Reynald, Maxwell, Denis, Jevnikar, Anthony M, Huner, Norm, Ma, Shengwu
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621204/ https://www.ncbi.nlm.nih.gov/pubmed/19014643 http://dx.doi.org/10.1186/1472-6750-8-87

Ejemplares similares

Subthalamic hGAD65 Gene Therapy and Striatum TH Gene Transfer in a Parkinson’s Disease Rat Model
por: Zheng, Deyu, et al.
Publicado: (2013)

Hypercapnic ventilatory response in mice lacking the 65 kDa isoform of Glutamic Acid Decarboxylase (GAD65)
por: Bissonnette, John M, et al.
Publicado: (2004)

High-yield expression of recombinant soybean agglutinin in plants using transient and stable systems
por: Tremblay, Reynald, et al.
Publicado: (2010)

Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome
Publicado: (1993)

Tobacco, a highly efficient green bioreactor for production of therapeutic proteins
por: Tremblay, Reynald, et al.
Publicado: (2010)

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes
Publicado: (1996)

Anti-Glutamic Acid Decarboxylase (GAD) 65 Encephalitis Mistaken for Herpes Encephalitis and Hashimoto’s Encephalitis (HE): A Case Report
por: Abu-Abaa, Mohammad, et al.
Publicado: (2023)

Assessment of CD4+ T Cell Responses to Glutamic Acid Decarboxylase 65 Using DQ8 Tetramers Reveals a Pathogenic Role of GAD65 121–140 and GAD65 250–266 in T1D Development
por: Chow, I-Ting, et al.
Publicado: (2014)

Amino acid residues 24-31 but not palmitoylation of cysteines 30 and 45 are required for membrane anchoring of glutamic acid decarboxylase, GAD65
Publicado: (1994)

Aberrant Accumulation of the Diabetes Autoantigen GAD65 in Golgi Membranes in Conditions of ER Stress and Autoimmunity
por: Phelps, Edward A., et al.
Publicado: (2016)

Two putative glutamate decarboxylases of Streptococcus pneumoniae as possible antigens for the production of anti-GAD65 antibodies leading to type 1 diabetes mellitus
por: García, Ernesto
Publicado: (2023)

Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes
por: Liu, Baoping, et al.
Publicado: (2016)

CD4(+) T Cells from Glutamic Acid Decarboxylase (GAD)65-specific T Cell Receptor Transgenic Mice Are Not Diabetogenic and Can Delay Diabetes Transfer
por: Tarbell, Kristin V., et al.
Publicado: (2002)

Gender Differences in Associations of Glutamate Decarboxylase 1 Gene (GAD1) Variants with Panic Disorder
por: Weber, Heike, et al.
Publicado: (2012)

Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic beta-cells by palmitoylation in the NH2-terminal domain
Publicado: (1992)

Determination of Glutamic Acid Decarboxylase (GAD65) in Pancreatic Islets and Its In Vitro and In Vivo Degradation Kinetics in Serum Using a Highly Sensitive Enzyme Immunoassay
por: Schlosser, Michael, et al.
Publicado: (2008)

Glutamic acid decarboxylase (anti-GAD) & tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity
por: Marwaha, R.K., et al.
Publicado: (2013)

Inhibition of glutamate decarboxylase (GAD) by ethyl ketopentenoate (EKP) induces treatment-resistant epileptic seizures in zebrafish
por: Zhang, Yifan, et al.
Publicado: (2017)

Weak Association Between the Glutamate Decarboxylase 1 Gene (GAD1) and Schizophrenia in Han Chinese Population
por: Zhang, Luwen, et al.
Publicado: (2021)

Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias
por: Mitoma, Hiroshi, et al.
Publicado: (2017)

The early detection of type 1 diabetes mellitus and latent autoimmune diabetes in adults (LADA) through rapid test reverse-flow immunochromatography for glutamic acid decarboxylase 65 kDa (GAD(65))
por: Aulanni'am, Aulanni'am, et al.
Publicado: (2021)

A comparative study of extraction techniques for maximum recovery of glutamate decarboxylase (GAD) from Aspergillus oryzae NSK
por: Lee Ying Yeng, Audrey, et al.
Publicado: (2013)

Concomitant Crohn’s Disease and Anti-Glutamic Acid Decarboxylase (GAD)-Associated Autoimmune Encephalitis: A Case Report
por: Akkoyun, Erkam, et al.
Publicado: (2023)

Epilepsy in patients with insulin-dependent diabetes and relation to glutamic acid decarboxylase 65
por: Mahmoud, Adel A., et al.
Publicado: (2020)

Bypassing Glutamic Acid Decarboxylase 1 (Gad1) Induced Craniofacial Defects with a Photoactivatable Translation Blocker Morpholino
por: O’Connor, Matthew J., et al.
Publicado: (2018)

Expression and Transformation Characteristics of a Novel Glutamic Acid Decarboxylase LcGAD10s and Its Application on Sufu Processing
por: Chen, Zhou, et al.
Publicado: (2023)

Elevated Serum GAD65 and GAD65-GADA Immune Complexes in Stiff Person Syndrome
por: Gu Urban, Gucci Jijuan, et al.
Publicado: (2015)

Decline in Titers of Anti-Idiotypic Antibodies Specific to Autoantibodies to GAD65 (GAD65Ab) Precedes Development of GAD65Ab and Type 1 Diabetes
por: Larsson, Helena Elding, et al.
Publicado: (2013)

Calpain Cleavage of Brain Glutamic Acid Decarboxylase 65 Is Pathological and Impairs GABA Neurotransmission
por: Buddhala, Chandana, et al.
Publicado: (2012)

An Analysis of the Cross-Reactivity of Autoantibodies to GAD65 and GAD67 in Diabetes
por: Jayakrishnan, Bindu, et al.
Publicado: (2011)

Spatially localised expression of the glutamate decarboxylase gadB in Escherichia coli O157:H7 microcolonies in hydrogel matrices
por: Saint Martin, Cédric, et al.
Publicado: (2023)

Meningoencephalitis associated with GAD65 autoimmunity
por: Kuang, Zuying, et al.
Publicado: (2023)

GAD65 Antibody-Associated Epilepsy
por: Valinčiūtė, Justina, et al.
Publicado: (2023)

How Much GAD65 Do You Have? High Levels of GAD65 Antibodies in Autoimmune Encephalitis
por: Gaspard, Nicolas
Publicado: (2020)

A Diagnostic Dilemma of Antiglutamic Acid Decarboxylase 65 (Anti-GAD 65) and Mycoplasma Pneumoniae Antibodies in a Girl Presenting with Acute-Onset Obsessive-Compulsive Disorder
por: Freeman, Cecilia G., et al.
Publicado: (2021)

Glutamic Acid Decarboxylase (GAD-65) Autoimmunity Associated With Profound Daytime Hypersomnia, Nighttime Insomnia, Mild Autonomic Neuropathy and Axonal Sensori-Motor Polyneuropathy: A Case Report on a New Phenotype
por: Kesserwani, Hassan
Publicado: (2020)

An analytical comparison of three immunoassay platforms for subpicomolar detection of protein biomarker GAD65
por: Costa, Olivier R., et al.
Publicado: (2018)

Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan
por: Yasui, Junichi, et al.
Publicado: (2016)

Are T-Cell Responses to GAD65 Influential in Type 1 Diabetes?
por: Quinn, Anthony
Publicado: (2009)

Severe anaphylactic reactions to glutamic acid decarboxylase (GAD) self peptides in NOD mice that spontaneously develop autoimmune type 1 diabetes mellitus
por: Pedotti, Rosetta, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_4nfgbevd0ru195ncj16aq00065